This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Aluvia (EU), Lopinavir and Ritonavir, LPV/r, ABT-378/r, Norvir
Description: Kaletra is a combination of Lopinavir and Ritonavir, (a previously approved protease inhibitor). Lopinavir's antiviral properties are combined with a low dose of Ritonavir that inhibits Lopinavir's metabolism. This results in blood levels of Lopinavir that enhance its effectiveness against HIV.
Additional information available to subscribers only: